Literature DB >> 19341416

Heart transplantation in the United States, 1998-2007.

J D Vega1, J Moore, S Murray, J M Chen, M R Johnson, D B Dyke.   

Abstract

This article highlights trends in heart transplantation from 1998 to 2007, using data from the Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR). The number of candidates actively awaiting heart transplantation has declined steadily, from 2525 in 1998 to 1408 in 2007, a 44% decrease. Despite this decline, a larger proportion of patients are listed as either Status 1A or 1B, likely secondary to increased use of mechanical circulatory support. During this time, the overall death rate among patients awaiting heart transplantation fell from 220 to 142 patients per 1000 patient-years at risk; this likely reflects better medical and surgical options for those with end-stage heart failure. This trend was noted across all racial groups, both sexes, all disease etiologies (retransplantation excepted) and all status groups. Recipient numbers were relatively stable over the past decade. In 2007, 2207 transplants were performed, although the proportion of patients transplanted as Status 1A shifted from 34% to 50%. A trend toward transplanting more patients above 65 years of age was seen. Adjusted patient (and graft) survival at 3 months, 1, 5 and 10 years after transplantation has gradually, but significantly, improved during the same period; current patient survival estimates are 93%, 88%, 74% and 55%, respectively.

Entities:  

Mesh:

Year:  2009        PMID: 19341416     DOI: 10.1111/j.1600-6143.2009.02568.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

Review 1.  The use of computational fluid dynamics in the development of ventricular assist devices.

Authors:  Katharine H Fraser; M Ertan Taskin; Bartley P Griffith; Zhongjun J Wu
Journal:  Med Eng Phys       Date:  2010-11-13       Impact factor: 2.242

2.  Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a german heart center.

Authors:  Thomas Strecker; Johannes Rösch; Michael Weyand; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 3.  Decellularized matrices for cardiovascular tissue engineering.

Authors:  Francesco Moroni; Teodelinda Mirabella
Journal:  Am J Stem Cells       Date:  2014-03-13

4.  Bioengineering Cardiac Tissue Constructs With Adult Rat Cardiomyocytes.

Authors:  Ze-Wei Tao; Mohamed Mohamed; Jeffrey G Jacot; Ravi K Birla
Journal:  ASAIO J       Date:  2018 Sep/Oct       Impact factor: 2.872

5.  Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.

Authors:  Marcus Franz; K Grün; P Richter; B R Brehm; M Fritzenwanger; K Hekmat; D Neri; J Gummert; H R Figulla; H Kosmehl; A Berndt; A Renner
Journal:  Histochem Cell Biol       Date:  2010-10-08       Impact factor: 4.304

6.  Sex matters, but to what clinical avail?

Authors:  Jennifer C Matthews; Keith D Aaronson
Journal:  Circ Heart Fail       Date:  2009-09       Impact factor: 8.790

Review 7.  Steroid-free and steroid withdrawal protocols in heart transplantation: the review of literature.

Authors:  Massimo Baraldo; Giorgia Gregoraci; Ugolino Livi
Journal:  Transpl Int       Date:  2014-04-12       Impact factor: 3.782

8.  Gene transfer of heme oxygenase-1 using an adeno-associated virus serotype 6 vector prolongs cardiac allograft survival.

Authors:  Jacqueline M Evans; Sonia Navarro; Tomoko Doki; John M Stewart; Noboru Mitsuhashi; Mary Kearns-Jonker
Journal:  J Transplant       Date:  2012-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.